CPTR — Captor Capital Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Captor Capital, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 5.87 | 12.5 | 16.2 | 32.7 |
Cost of Revenue | |||||
Gross Profit | — | 1.62 | 3.4 | 5.3 | 12.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.41 | 52 | 45.4 | 22.6 | 48.9 |
Operating Profit | -1.41 | -46.1 | -32.9 | -6.39 | -16.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3.78 | -46.1 | -32.9 | -6.39 | -16.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.78 | -46.4 | -32.9 | -7.06 | -18.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.78 | -46.4 | -32.9 | -5.87 | -14.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.78 | -46.4 | -32.9 | -5.87 | -14.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.4 | -0.778 | -0.83 | -0.145 | -0.212 |